The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.083%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 24.25
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Tremor Nasdaq IPO underway; MGC's CannEpil in Ireland

Tue, 15th Jun 2021 20:28

(Alliance News) - The following is a round-up of updates by London-listed companies issued on Monday and not separately reported by Alliance News:

----------

Tritax EuroBox PLC - investor in continental European logistics real estate assets - Starts work on on the 93,931 square metre extension to its global distribution centre asset at Llica d'Amunt, Barcelona, which is let to fashion retailer Punto Fa SL, trading as Mango. Company is financing the construction of the extension at a yield on cost of 8.8%, for an estimated capital commitment of EUR31.5 million.

----------

Tremor International Ltd - Tel Aviv-based advertising technology - Launches initial public offering on Nasdaq Global Market in New York of 6.8 million American depositary shares, representing an aggregate of 13.5 million shares. Each ADS represents two ordinary shares of Tremor. Notes last closing price of shares in London on Friday was GBP7.86. Closed at GBP8.00 on Tuesday.

----------

RTW Venture Fund Ltd - investment company focused on the life sciences sector - Participates in USD210 million Series B round in US-based privately held oncology company Umoja Biopharma Inc. "The proceeds from the Series B financing round are intended to enable Umoja to accelerate development of its pipeline of engineered immunotherapies and internal manufacturing capabilities," company explains.

----------

BATM Advanced Communications Ltd - Israel-based networking and medical technology company - Wins cyber security contract worth USD4.1 million, of which more than half will be delivered in the current year. "The contract has been awarded by the group's long-standing government defence department customer. The group will provide hardware and software as part of its network cyber security solution with delivery commencing immediately," company adds.

----------

Gresham House PLC - investor in smaller UK public companies - Court hearing for proposed capital reduction moved to June 29 from today, allowing notice of the hearing to be advertised for the period mandated by the Court.

----------

Sareum Holdings PLC - drug development company - Raises GBP1.5 million through subscription of 30.0 million shares at 4.9 pence each. Each subscriber will also be issued one five-year warrant, exercisable at the subscription price, for every three subscription shares issued. The net proceeds from the subscription will be used to progress the company's SDC-1801 and SDC-1802 TYK2/JAK1 inhibitor drug development programmes as well as for working capital purposes.

----------

Amino Technologies PLC - Cambridge-based broadcasting technology provider - Starts work with Hong Kong-based media firm PCCW Media to enable its Now TV video service. "Amino's software enables both PayTV and streaming services through an Android based user experience, including Netflix integration via Amino's Hailstorm Partnership with Netflix," company says. It adds: "Now TV is Hong Kong's leading Pay TV operator with the territory's largest subscriber base. PCCW plans to utilise Amino software to enhance its offering to deliver next generation viewing experiences, combining streaming services including Netflix within the service for the first time. The partnership utilises PCCW hardware with Amino's software solutions."

----------

Mirriad Advertising PLC - London-based company providing in-video advertising technology - Signs partnership with A+E Networks for in-content opportunities for brand partners. "In the fourth quarter 2020, both parties launched in collaboration a series of in-content activities within Lifetime holiday movies programming pillar, It's A Wonderful Lifetime. Following the success achieved during the collaboration, the A+E Networks team will begin to include in-content advertising for their agency and brand partners as part of their 2021-2022 Upfront opportunities," company explains.

----------

D4T4 Solutions PLC - Surrey, England-based IT services provider - Launches Celebrus Fraud Data Platform. Says will "support businesses in protecting their customers in real-time across all digital touchpoints." It adds: "This is the result of two years' design and development work and approximately GBP1.5 million of investment by the group and sees D4t4's initial launch into the large and growing market of fraud protection software, estimated to be worth currently USD18 billion per annum."

----------

IQGeo Group PLC - Cambridge, England-based geospatial software for telecom and utility network operators - Selected by the US Western Area Power Administration to support their electrical transmission line inspection process. "This new project will see the WAPA team using the IQGeo geospatial software in combination with its Inspection & Survey application. The software will be used by field teams conducting ground and aerial helicopter inspection patrols, and vegetation surveys," company adds.

----------

Condor Gold PLC - gold exploration and development in Nicaragua - Starts 1,700 metre infill geotechnical drilling programme within the permitted La India open pit in Nicaragua. Two diamond drill rigs have been deployed to expedite progress, company says. It adds: "The programme is anticipated to take 5 to 6 weeks to complete. The geotechnical drilling programme has been designed to achieve a feasibility level of design by SRK Consulting Ltd and will complement other ongoing feasibility study level work programmes already underway."

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Its cannabis derived epilepsy investigational medicinal product, CannEpil, has been added to the Primary Care Reimbursement Service in the Republic of Ireland as part of the Medicinal Cannabis Access Programme, making it free of charge for Irish patients prescribed the treatment under the MCAP. CannEpil is already being prescribed in Australia and the UK in the treatment epilepsy. Notes is saw best monthly revenue to date of more than AUD360,000, about USD276,000. Monthly sales revenue of over A$360,000 excludes all non-cannabinoid products.

----------

CIP Merchant Capital Ltd - AIM-listed closed-ended investment company incorporated in Guernsey - Buys further 150,000 shares in AIM-listed Ixico PLC for GBP120,000. Now holds interest in 3.4 million shares, or about 7.0%.

----------

Eastinco Mining & Exploration PLC - Musasa tantalum and tin metal project in Rwanda - Agrees terms and formally signs new joint venture agreement with an unnamed Rwandan entity to explore and develop mineral opportunities over an area covering 2,750 hectares in southern Rwanda on which the unnamed partner holds a license for the exploration and development of tantalum, niobium, tin and tungsten metal resources. Under the deal, Eastinco will create a new company, Kinunga Mining Ltd in Rwanda and hold 70% of its shares, with its partner holding the remaining 30%.

----------

Mosman Oil & Gas Ltd - New South Wales, Australia-based oil exploration, development and production company - Airborne gravity and gradiometry survey over EP 145, in the Amadeus Basin in the Northern Territory of Australia has now been approved by the relevant government department, company says. Work at EP 145 expects to start in the week commencing July 5.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
7 Dec 2023 14:31

UK shareholder meetings calendar - next 7 days

Friday 8 December 
Amedeo Air Four Plus LtdAGM
Ashoka India Equity Investment Trust PLCAGM
Associated British Engineering PLCAGM
Associated British Foods PLCAGM
Corcel PLCGM re disposal of 41% interest in the Mambare nickel/cobalt project
Hargreaves Lansdown PLCAGM
URA Holdings PLCGM re closing the fundraise
Monday 11 December 
IamFire PLCAGM with vote on name change to WeCap PLC
Pharma C Investments PLCGM re allowing investments in fintech, AI sectors
SigmaRoc PLCGM re reverse takeover
Tribal Group PLCGM re cash offer by Tiger Bidco 1 Ltd
Vela Technologies PLCAGM
Tuesday 12 December 
Atalaya Mining PLCEGM re redomiciliation to Spain from Cyprus
Blackrock Greater Europe Investment Trust PLCAGM
Distil PLCGM re placing and subscription
Gelion PLCAGM
Wednesday 13 December 
Dechra Pharmaceuticals PLCAGM
Limitless Earth PLCAGM
Softcat PLCAGM
Volution Group PLCAGM
Thursday 14 December 
Aeorema Communications PLCAGM
CleanTech Lithium PLCGM re equity raise approval
Driver Group PLCFull Year Results
eEnergy Group PLCAGM
Ethernity Networks LtdGM re authority to allot shares on non-preemptive basis
Fintech Asia LtdAGM
Helium One Global LtdAGM
Marwyn Value Investors LtdAGM
Quarto Group IncGM re cancelling trading on London's Main Market
Sareum Holdings PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
23 Nov 2023 14:28

IN BRIEF: Sareum Holdings draws down on equity prepayment facility

Sareum Holdings PLC - Cambridge, England-based pharmaceutical company, focused on developing kinase inhibitors to treat autoimmune diseases and cancer - Says that it has drawn down on the GBP300,000 second deposit in respect of a previously announced equity prepayment facility.

Read more
9 Nov 2023 13:47

EARNINGS AND TRADING: MetalNRG hails Gold Ridge findings

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
3 Nov 2023 13:59

Sareum secures Japan patent for kinase inhibitor asset

(Sharecast News) - Biotechnology firm Sareum announced on Friday that it has received a notice of allowance from the Japan Patent Office for a patent associated with SDC-1801, its primary TYK2/JAK1 kinase inhibitor.

Read more
3 Nov 2023 09:01

Sareum says patent notice in Japan boosts confidence in SDC-1801

(Alliance News) - Sareum Holdings PLC on Friday said it received a notice of allowance from Japan's Patent Office for a patent relating to its lead TYK2/JAK1 kinase inhibitor, SDC-1801.

Read more
9 Oct 2023 15:06

Sareum losses widen as clinical trials continue

(Sharecast News) - Biotechnology company Sareum Holdings reported a loss of £3.2m after tax in its final results on Monday, widening from last year's £2.2m due to heightened expenses from initiating clinical studies with SDC-1801, despite aligning with market anticipations.

Read more
9 Oct 2023 10:58

Sareum says earnings down but product development going well

(Alliance News) - Sareum Holdings PLC on Monday said its annual loss widened and its cash reserves are substantially reduced, but that development and testing of its medicinal products is progressing well.

Read more
6 Sep 2023 14:35

Director dealings: Blackbird, Sareum insiders pick up shares

(Sharecast News) - Blackbird found itself with a number of entries on the list of director buys on Wednesday, after a number of insiders and associates bought shares.

Read more
4 Sep 2023 09:18

Sareum begins dosing participants in phase 1a trial for SDC-1801

(Alliance News) - Sareum Holdings PLC on Monday said it has successfully started the multiple ascending dose part of its phase 1a clinical trial for its SDC-1801 drug, following approval from the safety review committee.

Read more
16 Aug 2023 13:13

Sareum flagship drug trial progressing well ahead of annual results

(Alliance News) - Sareum Holdings PLC on Wednesday said a clinical trial for its main therapeutic is continuing as planned, and it hopes to use a new prepayment facility to further enhance development.

Read more
3 Aug 2023 14:16

IN BRIEF: Sareum secures GBP5 million of funding from RiverFort Global

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune diseases and cancers - Agrees terms on equity prepayment facility of up to GBP5 million with RiverFort Global Opportunities PCC Ltd, as arranged by RiverFort Global Capital Ltd, with an initial deposit of GBP2 million. This is expected on August 4, net of associated costs.

Read more
26 Jun 2023 17:33

TRADING UPDATES: New patents for Sareum; Guanajuato hails assessment

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Monday and not separately reported by Alliance News:

Read more
26 Jun 2023 10:54

Sareum granted new patents in China, US

(Sharecast News) - Clinical-stage biotechnology developer Sareum announced the granting of patents for its lead kinase inhibitors in China and the United States on Monday.

Read more
6 Jun 2023 13:36

IN BRIEF: Sareum doses first subjects in psoriasis drug trial

Sareum Holdings PLC - Cambridge-based biotechnology company developing kinase inhibitors for autoimmune diseases and cancers - Announces successful dosing of first test subjects in a randomised, placebo-controlled phase 1a clinical trial for lead programme SDC-1801. SDC-1801 is a dual TYK2/JAK1 kinase inhibitor and potential new therapeutic for various autoimmune diseases with an initial focus on psoriasis. The phase 1a trial will investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of SDC-1801 in healthy subjects, in single and multiple ascending oral dose studies. Dosing has started in a specialist clinical unit in Melbourne, Australia. Sareum expects full safety data to become available during the first half of 2024, after which a phase 1b clinical study will commence post-haste if the Phase 1a trial obtains satisfactory results.

Read more
18 May 2023 14:31

TRADING UPDATES: Nuformix says NXP002 shows anti-inflammatory effect

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.